Position Statement: Vitamin D Intake to Prevent Osteoporosis and Fracture in Adults

키워드

참고문헌 (73)

1. NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy, "Osteoporosis prevention, diagnosis, and therapy", JAMA, 285, pp.785~795 (2001)[DOI]
2. Sözen T, "An overview and management of osteoporosis", Eur J Rheumatol, 4, pp.46~56 (2017)[DOI]
3. Partridge L, "Facing up to the global challenges of ageing", Nature, 561, pp.45~56 (2018)[DOI]
4. Korea Society for Bone and Mineral Research, "Osteoporosis and osteoporotic fracture fact sheet 2019", Korea Society for Bone and Mineral Research, National Health Insurance Service, ~ (2019)
5. 안승희, "Osteoporosis and Osteoporotic Fracture Fact Sheet in Korea", 대한골대사학회지, 27(4), pp.281~290 (2020), 대한골대사학회
6. "Press Releases: The enemy of middle-aged women, 「Osteoporosis」" (2020)[URL]
7. Yeam CT, "A systematic review of factors affecting medication adherence among patients with osteoporosis", Osteoporos Int, 29, pp.2623~2637 (2018)[DOI]
8. Polzonetti V, "Dietary intake of vitamin D from dairy products reduces the risk of osteoporosis", Nutrients, 12 (2020)[DOI]
9. Ramasamy I, "Vitamin D metabolism and guidelines for vitamin D supplementation", Clin Biochem Rev, 41, pp.103~126 (2020)[DOI]
10. Holick MF, "Vitamin D deficiency", N Engl J Med, 357, pp.266~281 (2007)[DOI]
11. Holick MF, "Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 96, pp.1911~1930 (2011)[DOI]
12. Rosen CJ, "The 2011 IOM report on vitamin D and calcium requirements for north america : clinical implications for providers treating patients with low bone mineral density", J Clin Densitom, 14, pp.79~84 (2011)[DOI]
13. Sawyer ME, "A physiologically based pharmacokinetic model of vitamin D", J Appl Toxicol, 37, pp.1448~1454 (2017)[DOI]
14. Bikle DD, "Vitamin D : an ancient hormone", Exp Dermatol, 20, pp.7~13 (2011)[DOI]
15. Dominguez LJ, "Vitamin D sources, metabolism, and deficiency: Available compounds and guidelines for its treatment", Metabolites, 11 (2021)[DOI]
16. Bischoff-Ferrari HA, "Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults", J Bone Miner Res, 24, pp.935~942 (2009)[DOI]
17. Cauley JA, "Serum 25-hydroxyvitamin D concentrations and risk for hip fractures", Ann Intern Med, 149, pp.242~250 (2008)[DOI]
18. Hou YC, "Role of nutritional vitamin D in osteoporosis treatment", Clin Chim Acta, 484, pp.179~191 (2018)[DOI]
19. You Hyejin, "Vitamin D intake and bone mineral density in Korean adults: analysis of the 2009–2011 Korea National Health and Nutrition Examination Survey", Nutrition Research and Practice, 16(6), pp.775~788 (2022), 한국영양학회[DOI]
20. Park JH, "Vitamin D status in South Korean population: Seven-year trend from the KNHANES", Medicine(Baltimore), 97, pp.e11032~ (2018)[DOI]
21. 김경민, "Calcium and Vitamin D Supplementations: 2015 Position Statement of the Korean Society for Bone and Mineral Research", 대한골대사학회지, 22(4), pp.143~149 (2015), 대한골대사학회
22. Francis RM, "National Osteoporosis Society practical clinical guideline on vitamin D and bone health", Maturitas, 80, pp.119~121 (2015)[DOI]
23. Institute of Medicine, Food and Nutrition Board, Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, "Dietary reference intakes for calcium and vitamin D" (2011), National Academies Press
24. World Health Organization, "Vitamin and mineral requirements in human nutrition" (2005), World Health Organization
25. Macdonald HM, "25-hydroxyvitamin D threshold for the effects of vitamin D supplements on bone density : Secondary analysis of a randomized controlled trial", J Bone Miner Res, 33, pp.1464~1469 (2018)[DOI]
26. Macdonald HM, "Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3 : a 1-year double-blind RCT in postmenopausal women", J Bone Miner Res, 28, pp.2202~2213 (2013)[DOI]
27. Reid IR, "Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults substudy of a randomized controlled trial", J Intern Med, 282, pp.452~460 (2017)[DOI]
28. Reid IR, "Effects of vitamin D supplements on bone mineral density : a systematic review and meta-analysis", Lancet, 383, pp.146~155 (2014)[DOI]
29. Bischoff-Ferrari HA, "A pooled analysis of vitamin D dose requirements for fracture prevention", N Engl J Med, 367, pp.40~49 (2012)[DOI]
30. LeBoffMS, "Effects of supplemental vitamin D on bone health outcomes in women and men in the VITamin D and OmegA-3 TriaL(VITAL)", J Bone Miner Res, 35, pp.883~893 (2020)[DOI]
31. Burt LA, "Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength : A randomized clinical trial", JAMA, 322, pp.736~745 (2019)[DOI]
32. Burt LA, "Adverse effects of high-dose vitamin D supplementation on volumetric bone density are greater in females than males", J Bone Miner Res, 35, pp.2404~2414 (2020)[DOI]
33. Sanders KM, "Annual high-dose oral vitamin D and falls and fractures in older women : a randomized controlled trial", JAMA, 303, pp.1815~1822 (2010)[DOI]
34. Ooms ME, "Prevention of bone loss by vitamin D supplementation in elderly women : a randomized double-blind trial", J Clin Endocrinol Metab, 80, pp.1052~1058 (1995)[DOI]
35. Trivedi DP, "Effect of four monthly oral vitamin D3(cholecalciferol)supplementation on fractures and mortality in men and women living in the community : randomised double blind controlled trial", BMJ, 326, pp.469~ (2003)[DOI]
36. Bischoff-Ferrari HA, "Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: The DO-HEALTH randomized clinical trial", JAMA, 324, pp.1855~1868 (2020)[DOI]
37. Aspray TJ, "Randomized controlled trial of vitamin D supplementation in older people to optimize bone health", Am J Clin Nutr, 109, pp.207~217 (2019)[DOI]
38. Deane A, "The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis", BMC Musculoskelet Disord, 8, pp.3~ (2007)[DOI]
39. Adami S, "Vitamin D status and response to treatment in post-menopausal osteoporosis", Osteoporos Int, 20, pp.239~244 (2009)[DOI]
40. McClung MR, "Romosozumab in postmenopausal women with low bone mineral density", N Engl J Med, 370, pp.412~420 (2014)[DOI]
41. Antoniucci DM, "Vitamin D insufficiency does not affect bone mineral density response to raloxifene", J Clin Endocrinol Metab, 90, pp.4566~4572 (2005)[DOI]
42. Yamamoto T, "Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg", day administered subcutaneously in Japanese patients with osteoporosis, 2013, pp.31, 199~205
43. Gorai I, "Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia", J Bone Miner Metab, 30, pp.349~358 (2012)[DOI]
44. Sugimoto T, "Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status", J Bone Miner Metab, 38, pp.848~858 (2020)[DOI]
45. Geller JL, "Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients", Endocr Pract, 14, pp.293~297 (2008)[DOI]
46. 한희수, "Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial", 대한골대사학회지, 28(2), pp.131~137 (2021), 대한골대사학회
47. Bertoldo F, "Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion", J Bone Miner Res, 25, pp.447~454 (2010)[DOI]
48. Suzuki T, "Vitamin D and calcium addition during denosumab therapy over a period of four years significantly improves lumbar bone mineral density in Japanese osteoporosis patients", Nutrients, 10 (2018)[DOI]
49. Miller PD, "Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis : A randomized clinical trial", JAMA, 316, pp.722~733 (2016)[DOI]
50. Cosman F, "Romosozumab treatment in postmenopausal women with osteoporosis", N Engl J Med, 375, pp.1532~1543 (2016)[DOI]
51. Saag KG, "Romosozumab or alendronate for fracture prevention in women with osteoporosis", N Engl J Med, 377, pp.1417~1427 (2017)[DOI]
52. Leder BZ, "Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis", J Clin Endocrinol Metab, 100, pp.697~706 (2015)[DOI]
53. Saag KG, "Teriparatide or alendronate in glucocorticoid-induced osteoporosis", N Engl J Med, 357, pp.2028~2039 (2007)[DOI]
54. Cosman F, "Changes in vitamin D metabolites during teriparatide treatment", Bone, 50, pp.1368~1371 (2012)[DOI]
55. Krege JH, "Teriparatide, osteoporosis, calcium, and vitamin D", N Engl J Med, 353, pp.634~635 (2005)
56. Choi HS, "Vitamin D insufficiency in Korea--a greater threat to younger generation : the Korea National Health and Nutrition Examination Survey(KNHANES)2008", J Clin Endocrinol Metab, 96, pp.643~651 (2011)[DOI]
57. Korea Meteorological Administration, "Estimation of exposure time required for vitamin D production in human skin", Korea Meteorological Administration, ~ (2016)
58. Miyauchi M, "The solar exposure time required for vitamin D3 synthesis in the human body estimated by numerical simulation and observation in Japan", J Nutr Sci Vitaminol(Tokyo), 59, pp.257~263 (2013)[DOI]
59. Isaia G, "Prevalence of hypovitaminosis D in elderly women in Italy : clinical consequences and risk factors", Osteoporos Int, 14, pp.577~582 (2003)[DOI]
60. Ministry of Health and Welfare, "Dietary reference intakes for Koreans 2020", Ministry of Health and Welfare, ~ (2020)
61. Wang J, "Asians have lower body mass index(BMI)but higher percent body fat than do whites : comparisons of anthropometric measurements", Am J Clin Nutr, 60, pp.23~28 (1994)[DOI]
62. DeLuca HF, "Overview of general physiologic features and functions of vitamin D", Am J Clin Nutr, 80, pp.1689s~1696s (2004)[DOI]
63. Fulgoni VL, 3rd, "Foods, fortificants, and supplements: Where do Americans get their nutrients?", J Nutr, 141, pp.1847~1854 (2011)[DOI]
64. Newman JC, "Nutrients in the US diet: Naturally occurring or enriched", fortified food and beverage sources, plus dietary supplements: NHANES 2009-2012, 2019, pp.149, 1404~1412
65. Black LJ, "An updated systematic review and meta-analysis of the efficacy of vitamin D food fortification", J Nutr, 142, pp.1102~1108 (2012)[DOI]
66. Tripkovic L, "Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status : a systematic review and meta-analysis", Am J Clin Nutr, 95, pp.1357~1364 (2012)[DOI]
67. levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action, "J Clin Endocrinol Metab", 2000, 4023~4027, https:
68. Gustafsson K, "Food-related health perceptions and food habits among older women", J Adv Nurs, 39, pp.164~173 (2002)[DOI]
69. Cannell JJ, "Use of vitamin D in clinical practice", Altern Med Rev, 13, pp.6~20 (2008)
70. 최한석, "Korean Society for Bone and Mineral Research Task Force Report: Perspectives on Intermittent High-dose Vitamin D Supplementation", 대한골대사학회지, 24(3), pp.141~145 (2017), 대한골대사학회[DOI]
71. Belostotsky V, "Vitamin D deficiency in children with renal disease", Arch Dis Child, 93, pp.959~962 (2008)[DOI]
72. Dev R, "Preliminary report : vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia", Oncologist, 16, pp.1637~1641 (2011)[DOI]
73. Quesada-Gomez JM, "Is calcifediol better than cholecalciferol for vitamin D supplementation?", Osteoporos Int, 29, pp.1697~1711 (2018)[DOI]

관련 논문AI추천